The development of drotrecogin alfa (activated) for the treatment of severe sepsis.

Int J Artif Organs

Lilly Laboratory for Clinical Research, Eli Lilly and Company, Indianapolis, Indiana 46285, USA.

Published: May 2004

Download full-text PDF

Source
http://dx.doi.org/10.1177/039139880402700504DOI Listing

Publication Analysis

Top Keywords

development drotrecogin
4
drotrecogin alfa
4
alfa activated
4
activated treatment
4
treatment severe
4
severe sepsis
4
development
1
alfa
1
activated
1
treatment
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!